Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130M
-
Number of holders
-
301
-
Total 13F shares, excl. options
-
133M
-
Shares change
-
+2.88M
-
Total reported value, excl. options
-
$5.02B
-
Value change
-
-$42.9M
-
Put/Call ratio
-
0.73
-
Number of buys
-
176
-
Number of sells
-
-154
-
Price
-
$37.76
Significant Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q1 2025
390 filings reported holding PCVX - Vaxcyte, Inc. - COMMON STOCK as of Q1 2025.
Vaxcyte, Inc. - COMMON STOCK (PCVX) has 301 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 133M shares
.
Largest 10 shareholders include FMR LLC (12.5M shares), RA CAPITAL MANAGEMENT, L.P. (12.2M shares), VANGUARD GROUP INC (12M shares), BlackRock, Inc. (10.6M shares), WELLINGTON MANAGEMENT GROUP LLP (6.42M shares), Capital Research Global Investors (6.11M shares), STATE STREET CORP (4.41M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.54M shares), Kynam Capital Management, LP (3.2M shares), and FRANKLIN RESOURCES INC (3.09M shares).
This table shows the top 301 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.